Discover
OPK
OPKO Health, Inc.
1.53
1 x 1.29
1 x 1.75
bid
ask
+
0.03
2.00%
1 @ 04:00 PM
1.53 +0.00 (0.00%)
| Ytd | 21.43% | |
| 1y | 15.04% |
1.49
day range
1.54
0.98
52 week range
1.61
| Open | 1.51 | Prev Close | 1.50 | Low | 1.49 | High | 1.54 | Mkt Cap | 1.16B |
| Vol | 2.93M | Avg Vol | 2.68M | EPS | -0.27 | P/E | N/A | Forward P/E | -4.78 |
| Beta | 1.49 | Short Ratio | 11.34 | Inst. Own | 27.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 1.31 | 200-d Avg | 1.31 | 1yr Est | 4.38 |
| Income Statement | |||
| Total Revenue | 124.20M | ||
| Revenues (USD) | 124.20M | ||
| Cost of Revenue | 78.44M | ||
| Gross Profit | 45.76M | ||
| Operating Expenses | 96.77M | ||
| Research and Development Expense | 29.20M | ||
| Selling, General and Administrative Expense | 48.61M | ||
| Operating Income | -51.02M | ||
| Interest Expense | 10.94M | ||
| Income Tax Expense | -6.11M | ||
| Net Income | -54.85M | ||
| Net Income Common Stock | -54.85M | ||
| Net Income Common Stock (USD) | -54.85M | ||
| Consolidated Income | -54.85M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -50.02M | ||
| Earning Before Interest & Taxes (USD) | -50.02M | ||
| Weighted Average Shares | 758.88M | ||
| Weighted Average Shares Diluted | 758.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 341.88M | ||
| Cash and Equivalents (USD) | 341.88M | ||
| Investments | 10.53M | ||
| Investments Non-Current | 10.53M | ||
| Trade and Non-Trade Receivables | 79.64M | ||
| Current Assets | 535.36M | ||
| Property, Plant & Equipment Net | 118.39M | ||
| Total Assets | 1.86B | ||
| Debt Current | 20.73M | ||
| Total Debt | 390.39M | ||
| Current Liabilities | 148.38M | ||
| Debt Non-Current | 369.66M | ||
| Total Liabilities | 652.19M | ||
| Accumulated Retained Earnings (Deficit) | -2.35B | ||
| Accumulated Other Comprehensive Income | -27.49M | ||
| Shareholders Equity | 1.20B | ||
| Shareholders Equity (USD) | 1.20B | ||
| Assets Non-Current | 1.32B | ||
| Total Debt (USD) | 390.39M | ||
| Goodwill and Intangible Assets | 978.62M | ||
| Inventory | 64.40M | ||
| Liabilities Non-Current | 503.80M | ||
| Trade and Non-Trade Payables | 44.18M | ||
| Tax Liabilities | 114.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.20M | ||
| Net Cash Flow from Financing | -5.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.17M | ||
| Capital Expenditure | -1.80M | ||
| Issuance (Purchase) of Equity Shares | -4.77M | ||
| Issuance (Repayment) of Debt Securities | -390.00K | ||
| Net Cash Flow from Investing | -1.80M | ||
| Net Cash Flow from Operations | -19.31M | ||
| Effect of Exchange Rate Changes on Cash | -908.00K | ||
| Share Based Compensation | 2.74M | ||